Sale!
Sale!
Metacard MR 35mg
Original price was: 60.0 ৳ .59.4 ৳ Current price is: 59.4 ৳ .
Name Metacard MR
Generic Trimetazidine dihydrochloride INN 35mg/tablet (modified release)
Type Tablet
In stock (can be backordered)
Metacard MR 35mg
You must be logged in to post a review.
No more offers for this product!
Shipping Policy
Refund Policy
Cancellation / Return / Exchange Policy
General Inquiries
There are no inquiries yet.
Related Products
-
Xyotil 20mg
Original price was: 80.0 ৳ .79.2 ৳ Current price is: 79.2 ৳ . -
Abecab 5/40 mg
Original price was: 150.0 ৳ .148.5 ৳ Current price is: 148.5 ৳ . -
Syndol Plus 325mg + 37.5mg
Original price was: 80.0 ৳ .79.2 ৳ Current price is: 79.2 ৳ . -
Zofen-TS 1.5mg
Original price was: 72.0 ৳ .71.3 ৳ Current price is: 71.3 ৳ . -
Flexifen 10mg
Original price was: 80.0 ৳ .79.2 ৳ Current price is: 79.2 ৳ . -
Clofenac 25mg
Original price was: 10.0 ৳ .9.9 ৳ Current price is: 9.9 ৳ . -
Rhine 150mg
Original price was: 30.0 ৳ .29.7 ৳ Current price is: 29.7 ৳ . -
Calbon M
Original price was: 150.0 ৳ .147.0 ৳ Current price is: 147.0 ৳ . -
Methipred 4mg
Original price was: 75.0 ৳ .74.3 ৳ Current price is: 74.3 ৳ . -
Abetis Plus 12.5mg
Original price was: 81.0 ৳ .80.2 ৳ Current price is: 80.2 ৳ . -
Ace tram 325-37.5mg
Original price was: 80.0 ৳ .79.2 ৳ Current price is: 79.2 ৳ . -
Filfresh®3mg 10 pis
Original price was: 46.0 ৳ .45.5 ৳ Current price is: 45.5 ৳ . -
Pantonix 20mg
Original price was: 70.0 ৳ .69.3 ৳ Current price is: 69.3 ৳ . -
Intafenac k 50mg
Original price was: 30.0 ৳ .29.7 ৳ Current price is: 29.7 ৳ . -
Xten 20mg
Original price was: 80.0 ৳ .79.2 ৳ Current price is: 79.2 ৳ . -
Dibenol 5mg
Original price was: 7.0 ৳ .6.9 ৳ Current price is: 6.9 ৳ . -
Musclex 50mg
Original price was: 50.0 ৳ .49.5 ৳ Current price is: 49.5 ৳ . -
Atova
Original price was: 100.0 ৳ .98.0 ৳ Current price is: 98.0 ৳ . -
Citapram 10mg
Original price was: 51.0 ৳ .50.5 ৳ Current price is: 50.5 ৳ . -
TORAX 10mg
Original price was: 101.0 ৳ .100.0 ৳ Current price is: 100.0 ৳ .
Reviews
There are no reviews yet.